Analytik Jena AG / Analytik Jena AG Announces Group Figures for the First Half of the Financial Year 2012/2013 . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
- Consolidated revenue of EUR 46.9 m generated, export remains strong
- Results below plan
- Ambitious second half of the financial year with good expectations
Jena (Germany), May 8, 2013 - Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) closed the first half of the financial year 2012/2013 with consolidated revenue of EUR 46.9 m and thus generated 2.0 % more than in the previous year. The manufacturer of analytical instrumentation technology, life science instruments and optoelectronics achieved an EBITDA totaling EUR 4.7 m (previous year: EUR 5.3 m) and an operating profit (EBIT) of EUR 2.6 m (previous year: EUR 3.3 m). In the second quarter Analytik Jena was in the line of its forecast and reached results at previous year's level concerning revenue and operating profit.
"The international business again was a substantial support for the revenue development in the first half of 2012/2013. We continued to gradually expand our export and drove our internationalization strategy with structural measures. Thus we are well prepared to reach our ambitious objectives in the second half of the financial year", says Klaus Berka, CEO of Analytik Jena AG.
Revenue Development and Segments
In the strongest market, Asia, the Group again surpassed the excellent sales of the previous year by approximately 7.9 %, generating EUR 18.9 m (previous year: EUR 17.5 m). The development in the European market is pleasing, where sales recovered slightly of late. Here, Analytik Jena generated consolidated revenue of EUR 11.0 m (previous year: EUR 10.6 m) in the first six months. In the home market of Germany, revenue declined slightly in the first half of 2012/2013, amounting to EUR 12.7 m (previous year: EUR 13.3 m). Revenue in America amounted to EUR 3.3 m (previous year: EUR 3.5 m).
The largest business unit Analytical Instrumentation again grew solidly by 4.0 % reaching approximately EUR 30.6 m (previous year: EUR 29.5 m) as of the end of the reporting period. Life Science business unit reached the sales level of the previous year at EUR 13.8 m (previous year: EUR 13.9 m). The business unit Optics generated revenue of EUR 2.5 m (previous year: EUR 2.6 m).
Earnings
The Group closed the reporting period with total EBITDA of EUR 4.7 m (previous year: EUR 5.3 m). This equated to a year-on-year decline of 11.7 %. EBIT, too, did not yet reach the previous year's level after six months, amounting to EUR 2.6 m (previous year: EUR 3.3 m). The Group posted consolidated net profit for the period of EUR 0.4 m (previous year: EUR 2.0 m). The share of this attributable to the shareholders of Analytik Jena AG totals EUR 0.3 m (previous year: EUR 1.8 m), which corresponds to basic and diluted earnings per share of EUR 0.05 (previous year: EUR 0.34).
Changes in Statement of Financial Position
The Group's total assets as of the balance sheet date on March 31, 2013 decreased from EUR 105.7 m (as of September 30, 2012) to EUR 102.0 m. In the reporting period, Analytik Jena reported equity of EUR 46.6 m (September 30, 2012: EUR 46.2 m). The equity ratio rose from 43.8 % as of September 30, 2012 to 45.7% as of March 31, 2013. The Group's cash and cash equivalents amounted to EUR 18.6 m as of the end of the reporting period (September 30, 2012: EUR 21.5 m). In the reporting period, Analytik Jena recorded operating cash flow of EUR 2.8 m (previous year: EUR 2.5 m).
Human Resources
As of the balance sheet date of March 31, 2013, the Group employed 815 staff, including 44 trainees (previous year: 813 employees, including 37 trainees).
Outlook
Analytik Jena AG expects a stable revenue development for the second half of the financial year 2012/2013 and assumes to compensate the weaker earnings after six months. The Company expects each for the business unit Analytical Instrumentation and Life Science revenue growth compared to the previous year. The Company assumes similar figures to the previous year for Optics. In line with its forecast for the 2012/2013 financial year Analytik Jena AG expects to achieve consolidated revenue of more than EUR 100.0 m for the first time. EBITDA is to be incresed again and operating profit (EBIT) is to match the previous year's level of EUR 6.0 m.
Further Information
The full financial report is available at http://berichte.analytik-jena.de/6-MonthReport_1213.pdf.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Analytik Jena AG via Thomson Reuters ONE
--- End of Message ---
Analytik Jena AG
Konrad-Zuse-Straße 1 Jena Germany
WKN: 521350 ;ISIN: DE0005213508;Index:Prime All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
